XML 41 R54.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
 
 
2011

 
2010

 
2009

Dividend yield
 
2.5
%
 
2.5
%
 
3.8
%
Expected volatility
 
34.61
%
 
47.35
%
 
43.78
%
Risk-free interest rate
 
1.71
%
 
1.28
%
 
1.61
%
Expected life of stock options granted during period (years)
 
7.4

 
6.5

 
6.25

Life of Employees’ Stock Purchase Plan (months)
 
6

 
5

 
9

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
Stock Options
 
2011
Shares in thousands
 
Shares

 
Exercise
Price (1)

Outstanding at beginning of year
 
60,823

 
$
33.85

Granted
 
10,607

 
$
38.25

Exercised
 
(5,667
)
 
$
25.89

Forfeited/Expired
 
(2,059
)
 
$
40.54

Outstanding at end of year
 
63,704

 
$
35.08

Remaining contractual life in years
 

 
5.46

Aggregate intrinsic value in millions
 
$
173

 


Exercisable at end of year
 
44,245

 
$
37.30

Remaining contractual life in years
 

 
4.19

Aggregate intrinsic value in millions
 
$
99

 


(1)
Weighted-average per share

Schedule of value of stock option plans
Additional Information about Stock Options
In millions, except per share amounts
 
2011

 
2010

 
2009

Weighted-average fair value per share of options granted
 
$
10.64

 
$
9.17

 
$
2.60

Total compensation expense for stock option plans
 
$
88

 
$
72

 
$
46

Related tax benefit
 
$
33

 
$
27

 
$
17

Total amount of cash received from the exercise of options
 
$
147

 
$
66

 
$

Total intrinsic value of options exercised (1)
 
$
66

 
$
30

 
$

Related tax benefit
 
$
24

 
$
11

 
$

(1)
Difference between the market price at exercise and the price paid by the employee to exercise the options.
Employees' Stock Purchase Plan [Member]
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]
Employees’ Stock Purchase Plan
 
2011
Shares in thousands
 
Shares

 
Exercise
Price (1)

Outstanding at beginning of year
 

 

Granted
 
10,831

 
$
23.00

Exercised
 
(8,564
)
 
$
23.00

Forfeited/Expired
 
(2,267
)
 
$
23.00

Outstanding and exercisable at end of year
 

 

(1)
Weighted-average per share

Schedule of value of employees' stock purchase plan
Additional Information about ESPP
In millions, except per share amounts
 
2011

 
2010

 
2009

Weighted-average fair value per share of purchase rights granted
 
$
11.39

 
$
11.90

 
$
1.00

Total compensation expense for ESPP
 
$
123

 
$
164

 
$
10

Related tax benefit
 
$
46

 
$
61

 
$
4

Total amount of cash received from the exercise of purchase rights
 
$
197

 
$
224

 
$
137

Total intrinsic value of purchase rights exercised (1)
 
$
98

 
$
147

 
$
38

Related tax benefit
 
$
36

 
$
54

 
$
14

(1)
Difference between the market price at exercise and the price paid by the employee to exercise the purchase rights.

Deferred Stock [Member]
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Nonvested Performance-based Units Activity [Table Text Block]
Deferred Stock
 
2011
Shares in thousands
 
Shares

 
Grant Date
Fair Value (1)

Nonvested at beginning of year
 
15,251

 
$
25.89

Granted
 
3,381

 
$
37.60

Vested
 
(3,302
)
 
$
39.45

Canceled
 
(194
)
 
$
26.95

Nonvested at end of year
 
15,136

 
$
25.53

(1)
Weighted-average per share

Schedule of value of deferred stock [Text Block]
Additional Information about Deferred Stock
In millions, except per share amounts
 
2011

 
2010

 
2009

Weighted-average fair value per share of deferred stock granted
 
$
37.60

 
$
27.89

 
$
11.70

Total fair value of deferred stock vested and delivered (1)
 
$
123

 
$
38

 
$
20

Related tax benefit
 
$
46

 
$
14

 
$
7

Total compensation expense for deferred stock awards
 
$
124

 
$
123

 
$
80

Related tax benefit
 
$
46

 
$
46

 
$
30

(1)
Includes the fair value of shares vested in prior years and delivered in the reporting year.

Performance Deferred Stock Awards [Member]
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Nonvested Performance-based Units Activity [Table Text Block]
Performance Deferred Stock
 
2011
Shares in thousands
 
Target
Shares
Granted 
(1)

 
Grant Date 
Fair Value (2) 

Nonvested at beginning of year
 
3,132

 
$
20.72

Granted
 
1,109

 
$
38.07

Vested
 
(2,210
)
 
$
17.98

Canceled
 
(127
)
 
$
27.30

Nonvested at end of year
 
1,904

 
$
33.57

(1)
At the end of the performance period, the actual number of shares issued can range from zero to 250 percent of the target shares granted.
(2)
Weighted-average per share

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]
Performance Deferred Stock Awards
 
Target
Shares
Granted (1)

 
Grant Date
Fair Value (2)

Shares in thousands
 
Performance Period
 
2011
 
January 1, 2011 – December 31, 2013
 
1,109

 
$
38.07

2010
 
January 1, 2010 – December 31, 2012
 
875

 
$
27.79

2009
 
October 1, 2009 – September 30, 2011
 
1,177

 
$
26.39

2009
 
January 1, 2009 – December 31, 2011
 
1,162

 
$
9.53

(1)
At the end of the performance period, the actual number of shares issued can range from zero to 250 percent of the target shares granted.
(2)
Weighted-average per share
Schedule of Additional Information About Performance Deferred Stock [Table Text Block]
Additional Information about Performance Deferred Stock
 
 
 
  
In millions
 
2011

 
2010

 
2009

Total fair value of performance deferred stock vested and delivered (1)
 
$
77

 
$
28

 
$
1

Related tax benefit
 
$
28

 
$
10

 
$

Total compensation expense for performance deferred stock awards (2)
 
$
36

 
$
143

 
$
(7
)
Related tax benefit
 
$
13

 
$
53

 
$
(2
)
(1)
Includes the fair value of shares vested in prior years and delivered in the reporting year.
(2)
Compensation expense in 2010 included $25 million related to the modification of equity instruments to liability instruments for certain executive employees.